- All > Medicine Information and Evidence for Policy > Information and Publications
- All > WHO Prequalification of Medical Products > WHO-UNICEF-UN Project
(2013; 28 pages)
The WHO Prequalification of Medicines Programme (PQP) aims to ensure that medicines bought for priority diseases meet global standards of quality, safety and efficacy, in order to optimize use of health resources and improve health outcomes. It was established in 2001 to address two broad challenges: insufficient in-country capacity to assess medicines quality; and the limited choice of affordable treatment for diseases affecting poor populations. By conducting a comprehensive quality assurance evaluation of priority medicines, validating numerous generic products and strengthening local capacity, PQP ensures that national and international agencies make sound public health and cost effective choices when purchasing medicines and supplying them through countries’ health systems.